Article 04 Feb 2019 New EU Regulation Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use European Union Healthcare
Article 04 Feb 2019 Europe—New Regulation (EU) 2019/5 Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use European Union Healthcare
Article 13 Dec 2018 Europe—General Court Confirms Obligation To Prove Significant Benefit Over All Authorized Medicinal Products, Including Those Authorized After The Submission Of The Marketing Authorization Application For The Future (Orphan) Product European Union Healthcare
Article 31 May 2018 European Commission's Update Of Guideline On Duplicate Marketing Authorizations To Cover Biosimilars European Union Healthcare